{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T03:35:54Z","timestamp":1776137754196,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.jocn.2019.07.019","type":"journal-article","created":{"date-parts":[[2019,7,21]],"date-time":"2019-07-21T23:11:44Z","timestamp":1563750704000},"page":"117-122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Do brain mets grow while you wait? A volumetric natural history assessment of brain metastases from time of diagnosis to gamma knife treatment"],"prefix":"10.1016","volume":"68","author":[{"given":"Robert J.","family":"Plunkett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara A.","family":"Barone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William E.","family":"Brady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristopher M.","family":"Attwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dheerendra","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2019.07.019_b0005","doi-asserted-by":"crossref","first-page":"114","DOI":"10.12703\/P6-114","article-title":"Brain metastasis and treatment","volume":"6","author":"Ahluwalia","year":"2014","journal-title":"F1000Prime Rep"},{"key":"10.1016\/j.jocn.2019.07.019_b0010","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1200\/JCO.2015.60.9503","article-title":"Treatment of brain metastases","volume":"33","author":"Lin","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jocn.2019.07.019_b0015","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10434-000-0333-1","article-title":"Stereotactic radiosurgery for brain metastases from breast cancer","volume":"7","author":"Firlik","year":"2000","journal-title":"Ann Surg Oncol"},{"issue":"suppl.1","key":"10.1016\/j.jocn.2019.07.019_b0020","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3171\/2016.7.GKS161541","article-title":"Clinical outcomes in patients with brain metastases from breast cancer treated with single-session radiosurgery or whole brain radiotherapy","volume":"125","author":"Mix","year":"2016","journal-title":"J Neurosurg"},{"key":"10.1016\/j.jocn.2019.07.019_b0025","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/(SICI)1097-0142(19980715)83:2<344::AID-CNCR19>3.0.CO;2-T","article-title":"Stereotactic radiosurgery for brain metastasis from renal cell carcinoma","volume":"83","author":"Mori","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.jocn.2019.07.019_b0030","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0360-3016(98)00272-7","article-title":"Stereotactic radiosurgery for cerebral metastatic melanoma: factors affecting local disease control and survival","volume":"42","author":"Mori","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jocn.2019.07.019_b0035","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.3171\/jns.2002.97.6.1276","article-title":"Radiosurgery for non-small cell lung carcinoma metastatic to the brain: long-term outcomes and prognostic factors influencing patient survival time and local tumor control","volume":"97","author":"Sheehan","year":"2002","journal-title":"J Neurosurg"},{"key":"10.1016\/j.jocn.2019.07.019_b0040","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jama.2016.9839","article-title":"Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases","volume":"316","author":"Brown","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jocn.2019.07.019_b0045","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S1470-2045(09)70263-3","article-title":"Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial","volume":"10","author":"Chang","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jocn.2019.07.019_b0050","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s13566-017-0296-5","article-title":"Brain and hippocampal doses in patients with repeated stereotactic radiosurgery for brain metastasis","volume":"6","author":"Rivers","year":"2017","journal-title":"J Radiat Oncol"},{"issue":"suppl.2","key":"10.1016\/j.jocn.2019.07.019_b0055","article-title":"Preservation of normal brain tissue in patients with multiple metastatic lesions using stereotactic radiosurgery (SRS)","volume":"96","author":"Rivers","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jocn.2019.07.019_b0060","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1470-2045(14)70061-0","article-title":"Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study","volume":"15","author":"Yamamoto","year":"2014","journal-title":"Lancet Oncol"},{"issue":"suppl.2","key":"10.1016\/j.jocn.2019.07.019_b0065","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3171\/2014.8.GKS141421","article-title":"Stereotactic radiosurgery for patients with multiple brain metastases: a case matched study comparing treatment results for patients with 2\u20139 versus 10 or more tumors","volume":"121","author":"Yamamoto","year":"2014","journal-title":"J Neurosurg"},{"key":"10.1016\/j.jocn.2019.07.019_b0070","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0360-3016(99)00507-6","article-title":"Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90\u201305","volume":"47","author":"Shaw","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jocn.2019.07.019_b0075","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijrobp.2015.05.001","article-title":"Interval from imaging to treatment delivery in the radiation surgery age: how long is too long?","volume":"93","author":"Seymour","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jocn.2019.07.019_b0080","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1748-717X-6-48","article-title":"Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis","volume":"6","author":"Minniti","year":"2011","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.jocn.2019.07.019_b0085","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3171\/2014.10.JNS141610","article-title":"Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors","volume":"123","author":"Sneed","year":"2015","journal-title":"J Neurosurg"},{"issue":"7","key":"10.1016\/j.jocn.2019.07.019_b0090","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S1470-2045(17)30429-1","article-title":"Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multi-cohort, open label, phase 2 trial","volume":"18","author":"Davies","year":"2017","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.jocn.2019.07.019_b0095","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S1470-2045(16)30053-5","article-title":"A phase II trial of pembrolizumab for patients with melanoma or non-small cell lung cancer and untreated brain metastases","volume":"17","author":"Goldberg","year":"2016","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.jocn.2019.07.019_b0100","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1200\/JCO.18.00204","article-title":"Long-term survival of patients with melanoma with active brain metastases treated with pembrolizumab on a phase II trial","volume":"37","author":"Kluger","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jocn.2019.07.019_b0105","doi-asserted-by":"crossref","first-page":"5818","DOI":"10.1158\/1078-0432.CCR-16-0064","article-title":"PI3K pathway inhibition achieves potent antitumor activity in melanoma brain metastases in vitro and in vivo","volume":"22","author":"Niessner","year":"2016","journal-title":"Clin Cancer Res"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586819307738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586819307738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:17:59Z","timestamp":1760822279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586819307738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":21,"alternative-id":["S0967586819307738"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2019.07.019","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Do brain mets grow while you wait? A volumetric natural history assessment of brain metastases from time of diagnosis to gamma knife treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2019.07.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}